Literature DB >> 12507896

Do alloreactivity and prolonged cold ischemia cause different elementary lesions in chronic allograft nephropathy?

Immaculada Herrero-Fresneda1, Joan Torras, Josep M Cruzado, Enric Condom, August Vidal, Marta Riera, Nuria Lloberas, Jeroni Alsina, Josep M Grinyo.   

Abstract

This study assesses the individual contributions of the nonalloreactive factor, cold ischemia (CI), and alloreactivity to late functional and structural renal graft changes, and examines the effect of the association of both factors on the progression of chronic allograft nephropathy. Lewis rats acted as receptors of kidneys from either Lewis or Fischer rats. For CI, kidneys were preserved for 5 hours. The rats were divided into four groups: Syn, syngeneic graft; SynI, syngeneic graft and CI; Allo, allogeneic graft; AlloI, allogeneic graft and CI. Renal function was assessed every 4 weeks for 24 weeks. Grafts were evaluated for acute inflammatory response at 1 week and for chronic histological damage at 24 weeks. Only when CI and allogenicity were combined did immediate posttransplant mortality occur, while survivors showed accelerated renal insufficiency that induced further mortality at 12 weeks after transplant. Solely ischemic rats developed renal insufficiency. Renal structural damage in ischemic rats was clearly tubulointerstitial, while significant vasculopathy and glomerulosclerosis appeared only in the allogeneic groups. There was increased infiltration of macrophages and expression of mRNA-transforming growth factor-beta1 in the ischemic groups, irrespective of the allogeneic background. The joint association of CI plus allogenicity significantly increased cellular infiltration at both early and late stages, aggravating tubulointerstitial and vascular damage considerably. In summary, CI is mainly responsible for tubulointerstitial damage, whereas allogenicity leads to vascular lesion. The association of both factors accelerates and aggravates the progression of experimental chronic allograft nephropathy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12507896      PMCID: PMC1851124          DOI: 10.1016/S0002-9440(10)63804-7

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  41 in total

Review 1.  Chronic allograft rejection. Do the Th2 cells preferentially induced by indirect alloantigen recognition play a dominant role?

Authors:  H Shirwan
Journal:  Transplantation       Date:  1999-09-27       Impact factor: 4.939

2.  Effect of ETA/ETB receptor antagonist administration on iNOS gene expression in a rat renal transplantation model.

Authors:  I Herrero; J Torras; J Bover; L I Espinosa; J M Cruzado; M Riera; M Hueso; N Lloberas; J Alsina; J M Grinyo
Journal:  Transplant Proc       Date:  1999-09       Impact factor: 1.066

Review 3.  Hypothesis: is renal allograft rejection initiated by the response to injury sustained during the transplant process?

Authors:  C Y Lu; J G Penfield; M L Kielar; M A Vazquez; D R Jeyarajah
Journal:  Kidney Int       Date:  1999-06       Impact factor: 10.612

Review 4.  Rethinking chronic allograft nephropathy: the concept of accelerated senescence.

Authors:  P F Halloran; A Melk; C Barth
Journal:  J Am Soc Nephrol       Date:  1999-01       Impact factor: 10.121

5.  Late graft dysfunction after prolonged cold ischemia of the donor kidney: inhibition by cyclosporine.

Authors:  E A Kouwenhoven; R W de Bruin; U W Heemann; R L Marquet; J N Ijzermans
Journal:  Transplantation       Date:  1999-10-15       Impact factor: 4.939

6.  CD28-b7 blockade in organ dysfunction secondary to cold ischemia/reperfusion injury.

Authors:  A Chandraker; M Takada; K C Nadeau; R Peach; N L Tilney; M H Sayegh
Journal:  Kidney Int       Date:  1997-12       Impact factor: 10.612

7.  Prevention of late renal changes after initial ischemia/reperfusion injury by blocking early selectin binding.

Authors:  M Takada; K C Nadeau; G D Shaw; N L Tilney
Journal:  Transplantation       Date:  1997-12-15       Impact factor: 4.939

8.  Prevention of cold ischaemia-reperfusion injury by an endothelin receptor antagonist in experimental renal transplantation.

Authors:  I Herrero; J Torras; M Riera; E Condom; O Coll; J M Cruzado; M Hueso; J Bover; N Lloberas; J Alsina; J M Grinyó
Journal:  Nephrol Dial Transplant       Date:  1999-04       Impact factor: 5.992

Review 9.  Chronic allograft nephropathy: An update.

Authors:  L C Paul
Journal:  Kidney Int       Date:  1999-09       Impact factor: 10.612

10.  The Banff 97 working classification of renal allograft pathology.

Authors:  L C Racusen; K Solez; R B Colvin; S M Bonsib; M C Castro; T Cavallo; B P Croker; A J Demetris; C B Drachenberg; A B Fogo; P Furness; L W Gaber; I W Gibson; D Glotz; J C Goldberg; J Grande; P F Halloran; H E Hansen; B Hartley; P J Hayry; C M Hill; E O Hoffman; L G Hunsicker; A S Lindblad; Y Yamaguchi
Journal:  Kidney Int       Date:  1999-02       Impact factor: 10.612

View more
  12 in total

1.  Murine cytomegalovirus dissemination but not reactivation in donor-positive/recipient-negative allogeneic kidney transplantation can be effectively prevented by transplant immune tolerance.

Authors:  Anil Dangi; Shuangjin Yu; Frances T Lee; Melanie Burnette; Jiao-Jing Wang; Yashpal S Kanwar; Zheng J Zhang; Michael Abecassis; Edward B Thorp; Xunrong Luo
Journal:  Kidney Int       Date:  2020-02-21       Impact factor: 10.612

2.  Serum Iron Protects from Renal Postischemic Injury.

Authors:  Céline Vaugier; Mariane T Amano; Jonathan M Chemouny; Michael Dussiot; Claire Berrou; Marie Matignon; Sanae Ben Mkaddem; Pamella H M Wang; Aurélie Fricot; Thiago T Maciel; Damien Grapton; Jacques R R Mathieu; Carole Beaumont; Marie-Noëlle Peraldi; Carole Peyssonnaux; Laurent Mesnard; Eric Daugas; François Vrtovsnik; Renato C Monteiro; Olivier Hermine; Yelena Z Ginzburg; Marc Benhamou; Niels O S Camara; Martin Flamant; Ivan C Moura
Journal:  J Am Soc Nephrol       Date:  2017-08-07       Impact factor: 10.121

3.  HMGB1 contributes to kidney ischemia reperfusion injury.

Authors:  Huiling Wu; Jin Ma; Peng Wang; Theresa M Corpuz; Usha Panchapakesan; Kate R Wyburn; Steven J Chadban
Journal:  J Am Soc Nephrol       Date:  2010-09-16       Impact factor: 10.121

4.  Mesenchymal stem cell therapy prevents interstitial fibrosis and tubular atrophy in a rat kidney allograft model.

Authors:  Marcella Franquesa; Esther Herrero; Joan Torras; Elia Ripoll; Maria Flaquer; Montse Gomà; Nuria Lloberas; Ignacio Anegon; Josep M Cruzado; Josep M Grinyó; Immaculada Herrero-Fresneda
Journal:  Stem Cells Dev       Date:  2012-05-18       Impact factor: 3.272

5.  IL-18 contributes to renal damage after ischemia-reperfusion.

Authors:  Huiling Wu; Melissa L Craft; Peng Wang; Kate R Wyburn; Gang Chen; Jin Ma; Brett Hambly; Steven J Chadban
Journal:  J Am Soc Nephrol       Date:  2008-09-24       Impact factor: 10.121

Review 6.  Soluble biglycan as a biomarker of inflammatory renal diseases.

Authors:  Louise Tzung-Harn Hsieh; Madalina-Viviana Nastase; Jinyang Zeng-Brouwers; Renato V Iozzo; Liliana Schaefer
Journal:  Int J Biochem Cell Biol       Date:  2014-08-01       Impact factor: 5.085

7.  TLR4 activation mediates kidney ischemia/reperfusion injury.

Authors:  Huiling Wu; Gang Chen; Kate R Wyburn; Jianlin Yin; Patrick Bertolino; Josette M Eris; Stephen I Alexander; Alexandra F Sharland; Steven J Chadban
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

8.  Low-dose carbon monoxide inhibits progressive chronic allograft nephropathy and restores renal allograft function.

Authors:  Atsunori Nakao; Gaetano Faleo; Michael A Nalesnik; Joao Seda-Neto; Junichi Kohmoto; Noriko Murase
Journal:  Am J Physiol Renal Physiol       Date:  2009-04-15

9.  Hepatocyte growth factor gene therapy enhances infiltration of macrophages and may induce kidney repair in db/db mice as a model of diabetes.

Authors:  M Flaquer; M Franquesa; A Vidal; N Bolaños; J Torras; N Lloberas; I Herrero-Fresneda; J M Grinyó; J M Cruzado
Journal:  Diabetologia       Date:  2012-03-30       Impact factor: 10.122

10.  C3a and C5a promote renal ischemia-reperfusion injury.

Authors:  Qi Peng; Ke Li; Lesley A Smyth; Guolan Xing; Naiyin Wang; Lucy Meader; Bao Lu; Steven H Sacks; Wuding Zhou
Journal:  J Am Soc Nephrol       Date:  2012-07-12       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.